<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="78914">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01875146</url>
  </required_header>
  <id_info>
    <org_study_id>vyc</org_study_id>
    <nct_id>NCT01875146</nct_id>
  </id_info>
  <brief_title>Effects of High-intensity Interval Training in Combination With Side-alternating Whole-body Vibration</brief_title>
  <official_title>Effects of High-intensity Interval Training in Combination With Side-alternating Whole-body Vibration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of the training effects following 8 weeks of high-intensity interval training
      (HIT)in combination with side-alternating whole-body vibration compared to conventional HIT
      or side-alternating whole-body vibration. The adaptations are investigated on a molecular
      (muscle biopsy of the M. vastus lateralis) and systemic (e.g. cycling, jumping
      mechanography, dynamometry) level. In addition, the acute effects of the first and last
      training session will be investigated on a molecular (e.g. satellite cell activation, mRNA
      abundance) and systemic (e.g. ventilatory ga exchange, heart rate, rating of perceived
      exertion) level.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Change from baseline in Critical Power</measure>
    <time_frame>8 weeks intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>The differences in changes in Critical Power [Watts] are compared between the 4 training groups. For this purpose, participants complete before and after the training intervention an incremental cycling ramp test and 4 cycling constant-load tests.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Health Behavior</condition>
  <arm_group>
    <arm_group_label>4x4 min HIT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional 4x4 min high-intensity interval training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4x4 min HIT + WBV (18 Hz)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4x4 min high-intensity interval training in combination with whole-body vibration at 18 Hz during the active rest</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4x4 min HIT + WBV (30 Hz)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4x4 min high-intensity interval training in combination with whole-body vibration at 30 Hz during the active rest</description>
  </arm_group>
  <arm_group>
    <arm_group_label>whole-body vibration at 30 Hz</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4x3 min whole-body vibration at 30 Hz</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>4x4 min HIT</intervention_name>
    <description>Conventional 4x4 min high-intensity interval training</description>
    <arm_group_label>4x4 min HIT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>4x4 min HIT + WBV (18 Hz)</intervention_name>
    <description>4x4 min high-intensity interval training in combination with whole-body vibration at 18 Hz during the active rest</description>
    <arm_group_label>4x4 min HIT + WBV (18 Hz)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>4x4 min HIT + (30 Hz)</intervention_name>
    <description>4x4 min high-intensity interval training in combination with whole-body vibration at 30 Hz during the active rest</description>
    <arm_group_label>4x4 min HIT + WBV (30 Hz)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>whole-body vibration at 30 Hz</intervention_name>
    <description>4x3 min whole-body vibration at 30 Hz</description>
    <arm_group_label>whole-body vibration at 30 Hz</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria: - male

          -  no fever / no common cold at the beginning of the study

          -  between 18 and 35 years of age

          -  non-smoker

          -  no known cardiovascular or orthopedic problems

          -  no cardiac pacemaker

          -  fullfills healts questionnaire's requirements

        Exclusion criteria: - female

          -  fever / common cold at beginning of study

          -  age under 18 oder above 35y

          -  smoker

          -  cardiovascular or orthopedic problems

          -  cardiac pacemaker

          -  does not fullfill health questionnaire's requirements
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans H Jung, Prof MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of Neurology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Division of Neurology</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>January 6, 2014</lastchanged_date>
  <firstreceived_date>May 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
